# Teriparatide vs bisphosphonates: fractures and bone density

Source: https://pepvault.app/research/teriparatide-li-2024

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Teriparatide](https://pepvault.app/research#teriparatide)

Meta-analysis · people

# Teriparatide cut fracture risk vs bisphosphonates (RR 0.61)

Checked against the paper November 2026 Meta-analysis [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

Across 23 head-to-head trials, teriparatide beat bisphosphonates on fracture risk and bone density in people not previously on a bisphosphonate, without more adverse events.

- **Kind:** Meta-analysis
- **Studied in:** People
- **Number studied:** 6680
- **Published:** 2024
- **Journal:** Arch Osteoporos

## What they tested

The team set out to compare how well and how safely teriparatide and denosumab work against bisphosphonates in people with osteoporosis who had never taken a bisphosphonate.

## How the study was done

A systematic review and meta-analysis, which pools results from many studies, of 23 head-to-head randomized controlled trials with 6680 patients in total. Each trial compared teriparatide or denosumab directly with a bisphosphonate.

<!--promo-->

PepVault for iPhone

## Taking teriparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

Teriparatide lowered the risk of fracture compared with bisphosphonates, with a risk ratio (RR, how the risk in one group compares with the other) of 0.61 (95% CI 0.51 to 0.74, P < 0.001). Denosumab did not lower fracture risk compared with bisphosphonates (RR 0.99, 95% CI 0.62 to 1.57, P = 0.96). Both teriparatide and denosumab raised bone mineral density, a measure of how dense the bone is, at the femoral neck, total hip and lumbar spine more than bisphosphonates did (P < 0.05). Neither raised the rate of adverse events: teriparatide RR 0.92 (P = 0.32) and denosumab RR 0.98 (P = 0.37).

## What it doesn’t show

The pooled trials differed from each other clinically, so the team used both fixed-effect and random-effect models. It covers only people who had not had a bisphosphonate before, so it doesn't speak to people switching from one.

## The paper

Li et al. Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials. Arch Osteoporos. 2024.

- [PubMed (PMID 39312040)](https://pubmed.ncbi.nlm.nih.gov/39312040/)
- [The paper (DOI 10.1007/s11657-024-01447-7)](https://doi.org/10.1007/s11657-024-01447-7)

## The compound

- [Teriparatide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/teriparatide)
- [Teriparatide dose guide](https://pepvault.app/lab/dosage/teriparatide)

## With this study

### Teriparatide

- [Teriparatide: the full reference](https://pepvault.app/peptides/teriparatide)
- [Teriparatide dose guide](https://pepvault.app/lab/dosage/teriparatide)

### Studies

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025)
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023)
- [All 10 studies](https://pepvault.app/research#teriparatide)

### Compared with

- [Teriparatide vs Abaloparatide](https://pepvault.app/peptides/compare/teriparatide-vs-abaloparatide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Randomized controlled trial (RCT)](https://pepvault.app/glossary/randomized-controlled-trial)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)
- [Bone mineral density (BMD)](https://pepvault.app/glossary/bone-mineral-density)

## More studies on Teriparatide

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025) Meta-analysis · people · 2025
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023) Meta-analysis · people · 2023
- [Teriparatide: more bony union at 6 months than zoledronate after PLIF](https://pepvault.app/research/teriparatide-xiong-2022) Randomized trial · people · 2022
- [Teriparatide: 45.4% of jaw osteonecrosis lesions resolved by 52 weeks](https://pepvault.app/research/teriparatide-sim-2020) Randomized trial · people · 2020
- [Teriparatide: fewer new vertebral fractures than risedronate in VERO](https://pepvault.app/research/teriparatide-vero-2018) Randomized trial · people · 2018
- [Teriparatide then denosumab: spine density up 18.3% over 4 years](https://pepvault.app/research/teriparatide-data-switch-2015) Randomized trial · people · 2015
- [Every study on Teriparatide](https://pepvault.app/research#teriparatide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking teriparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking teriparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Teriparatide

- [Teriparatide: the full reference](https://pepvault.app/peptides/teriparatide)
- [Teriparatide dose guide](https://pepvault.app/lab/dosage/teriparatide)

### Studies

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025)
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023)
- [All 10 studies](https://pepvault.app/research#teriparatide)

### Compared with

- [Teriparatide vs Abaloparatide](https://pepvault.app/peptides/compare/teriparatide-vs-abaloparatide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Randomized controlled trial (RCT)](https://pepvault.app/glossary/randomized-controlled-trial)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)
- [Bone mineral density (BMD)](https://pepvault.app/glossary/bone-mineral-density)

<!--promo-->

PepVault for iPhone

## Taking teriparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Teriparatide](https://pepvault.app/research#teriparatide)

## The library

- [Teriparatide](https://pepvault.app/peptides/teriparatide)
- [Teriparatide dose guide](https://pepvault.app/lab/dosage/teriparatide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
